The US Food and Drug Administration (FDA) has notified healthcare providers of a class 1 recall of CareFusion's Alaris PC unit (model 8015) with software version 9.12. The Alaris PC unit is the ...

BD will pay a $175 million civil penalty to settle charges from the Securities and Exchange Commission that the company misled investors about problems with its Alaris infusion pumps. The SEC issued a ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...

Becton, Dickinson and Company’s (BDX Quick Quote BDX - Free Report) , or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, ...

CareFusion Corporation has initiated a class 1 recall of the Alaris PC unit model 8015 with software version 9.12 because of a voltage problem, according to the US Food and Drug Administration (FDA).

After facing down more than a dozen serious recalls in the last decade, BD’s Alaris infusion pump is involved in yet another wide-ranging Class I recall, this time for a bezel piece installed by ...

(RTTNews) - Becton, Dickinson and Co. (BDX) or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S. Securities and Exchange Commission to resolve an ...

The Syndeo pump could be reintroduced after Baxter fixes its design problems. CDRH has historically been suspicious about the reliability of infusion pumps. Incidents with two pump makers in 2006 have ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...

DUBLIN, Ohio, Feb. 6 (UPI) -- Cardinal Health said Tuesday it has struck an agreement with the U.S. Food and Drug Administration to resume sales of its Alaris SE Infusion Pump. The deal calls for the ...